Revance Therapeutics, Inc. - COM (RVNC)

Q4 2017 13F Holders as of 12/31/2017

Type / Class
Equity / COM
Number of holders
116
Total Shares
35M
Shares change
+4.37M
Total reported value, excl. options
$1.25B
Value change
+$169M
Put/Call ratio
1.93
Number of buys
77
Number of sells
-26
Price
$35.75
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.